Common Technical Document (CTD)

A CTD is a format used by pharmaceutical companies when submitting their marketing applications to the International Conference on Harmonization (ICH).

    More information about Common Technical Document (CTD)

    Module,documents,registration,files,safety,drug,dossiers,Canada,Health Canada,list,regulatory authorities,regulatory requirements,guidance document,structure,trial,regulatory activities,procedure,issues,common format.

    Relevant documents,technical document,drug regulatory,validation,scope,activities,industry,- Procedures,meetings,methods,active ingredient,application forms,original submission,separate documents,document for illustrations,document button.

    Pdf document,document content,document for responses,document headings,document Table,electronic source document,incorrect documents,legal document,multi-page PDF document,non-eCTD formatResponse document,placement of documents.

    Requirements for documents,electronic documents,Veterinary Drug,Drug Identification Number,Application for Drug Identification Number,drug product,Biological Drugs,Veterinary Drug Post,Veterinary Drug PSUR,MF Type I – Drug,Cover Letter.pdfSub-subfolder:1.5 Drug Submission ApplicationDocuments,drug notification form,Drug ShortageWhen,pdf file,file names,acceptable file formats,Distribution of master file,file path,Master file enquiries email,regulatory transaction xml file,size of files,content files,digits for master file,process validation,non-eCTD validation rules,technical validation errors,validation criteria,validation report,validation software,sample module,folders in module,correspondence in module,email for Module,letter in module 1.0.1,folder structure requirements,folder structures,incorrect structure,F-3: example folder structure,Equipment-3.2.A.2Adventitious Agents Safety Evaluation-,Agents Safety Evaluation-3.2.A.3Excipients-3.2.R.1.1Executed Production,Equipment-3.2.A.2Adventitious Agents Safety,Equipment-3.2.A.2Adventitious Agents Safety Evaluation-3.2.A.3Excipients-3.2.R.1.1Executed Production,Dossier Identifier,submission of dossiers,Dossier typeDossier,dossier typesFigure,Correspondence-1.0.4Health Canada,Health Canada Building,detailed list,complete list,List of Documents provided,registration process,registration of pharmaceuticals,registration steps,activities in scope,scope of REPTransactions,Transactions within scope,dmf.enquiries-fmm@hc-sc.gc.caClinical trial applications,pdd-pv-dmp@hc-sc.gc.caClinical trial applications,regulatory activity level,Industry – Management,Industry – Preparation,centralised procedure,compliance issues,manual processing issues,(e.g., pre-submission meetings,Presentations for meetings,acceptable method,method of transmissions.

    Why trust Agatha Life during your clinical trials?

    Every day, more than 200 companies trust Agatha to manage their clinical trial documentation
    Mablink
    Gustave Roussy
    Beyond Spring
    Clinical Services
    NS Pharma
    Share via
    Copy link
    Powered by Social Snap